Cannabis Weekly Round-Up: LPs Sign Deal with New Brunswick for Recreational Cannabis
The Investing News rounds some of the biggest news in the cannabis market for the past trading week
Your trusted source for investing success
Your trusted source for investing success
The Investing News rounds some of the biggest news in the cannabis market for the past trading week
Two of the biggest cannabis producers in Canada respond to the outline Ontario plans to follow on the road to cannabis legalization.
By Jocelyn Aspa
The Canadian marijuana sector is one of the hottest growing sectors. Here’s a look at Canadian cannabis companies for investors to consider.
The Investing News reported took a closer look at some of the big cannabis news of the week and published an interview with the president of Cannabis Wheaton.
Aphria alongside its partners in the US cannabis space Liberty Health Sciences released a response on Monday regarding the clarification by the TMX Group on regulatory engagement for cannabis companies listed in Canada but with business activities in the US.
This past trading in the cannabis marketplace saw another major dip to the Marijuana Life Sciences Index, the first medical marijuana study funded by a US medical government research group.
By Shelly Kumar
CannaRoyalty CEO Marc Lustig speaks to Business News Network (BNN) regarding recent market confusion and policy changes in the Canadian Depository for Securities Ltd. (CDS) affecting Canadian-listed cannabis companies
Click here to watch full interview
Expansions into the US from Canadian cannabis companies offer investors an opportunity to see returns from rapidly adopting pocket markets all over the country, now Aphria is offering an opportunity in the state of Florida with Liberty Health Sciences.
From Canadian LPs banding together asking for tougher promotional regulations to the acquisition of ABcann by Cannabis Wheaton and a variety of market news INN provides a roundup of the week in cannabis.
A new report from a cannabis-focused investment bank and advisory platform provided an insight into just how much money was invested in the Canadian cannabis market so far in 2017.
The introduction of advertising regulations with support from Advertising Standards Canada (ASC) to be adopted in the branding and promotion of cannabis.
From Uruguay’s full legalization to the debate between regional leaders in Canada questioning the recreational deadline, and a variety of market news INN provides a roundup of the week in cannabis
The company will be able to sell psychoactive cannabis for non-medical use in pharmacies beginning July 19.
With recreational use of cannabis set to be fully legalized in Canada next year, speculation is circulating as to whether or not there will be enough market supply.
A quick look of some of the major events in the cannabis industry this week.
Aurora Cannabis Inc. (the “Company” or “Aurora”) (TSX-V:ACB) (OTCQX:ACBFF) (Frankfurt:21P; WKN:A1C4WM) and WeedMD Inc. (TSXV:WMD) are pleased to announce that the companies have entered into a strategic relationship whereby WeedMD will provide wholesale dried medical cannabis to Aurora, and Aurora will provide best in class patient education services for WeedMD through its
By Pia Rivera
Two cannabis companies have joined Cannabis Investing News: Friday Night Inc. (CSE:TGIF, FWB:1QF, OTC:VPGDF) and PUF Ventures (CSE:PUF, Frankfurt:PU3, OTCPK:PUFXF).
The president of Mexico Enrique Pena Nieto released a decree on June 19 amending the law to effectively allow for the medical cannabis market to enter the country.
MYM Nutraceuticals Inc. (CSE:MYM) (OTC: MYMMF ) , is pleased to announce today that it has been made eligible for DTC electronic settlement and transfer of its common shares in the United States under the OTC symbol MYMMF.
This approval opens MYM up to the most important and influential investment market
The CEO of Canadian Bioceutical Corporation talks to us about their new acquisition and the opportunities for cannabis in Nevada.
